622 related articles for article (PubMed ID: 17437904)
1. Levetiracetam monotherapy in children with epilepsy.
Khurana DS; Kothare SV; Valencia I; Melvin JJ; Legido A
Pediatr Neurol; 2007 Apr; 36(4):227-30. PubMed ID: 17437904
[TBL] [Abstract][Full Text] [Related]
2. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study.
Callenbach PM; Arts WF; ten Houten R; Augustijn P; Gunning WB; Peeters EA; Weber AM; Stroink H; Geerts Y; Geerts AT; Brouwer OF
Eur J Paediatr Neurol; 2008 Jul; 12(4):321-7. PubMed ID: 17950011
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of zonisamide monotherapy in a cohort of children with epilepsy.
Kothare SV; Kaleyias J; Mostofi N; Valencia I; Melvin JJ; Hobdell E; Khurana DS; Legido A
Pediatr Neurol; 2006 May; 34(5):351-4. PubMed ID: 16647993
[TBL] [Abstract][Full Text] [Related]
4. Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures.
Glauser TA; Ayala R; Elterman RD; Mitchell WG; Van Orman CB; Gauer LJ; Lu Z;
Neurology; 2006 Jun; 66(11):1654-60. PubMed ID: 16641323
[TBL] [Abstract][Full Text] [Related]
5. Levetiracetam versus carbamazepine monotherapy for partial epilepsy in children less than 16 years of age.
Perry S; Holt P; Benatar M
J Child Neurol; 2008 May; 23(5):515-9. PubMed ID: 18182645
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of adjunctive levetiracetam therapy in pediatric intractable epilepsy.
Lee YJ; Kang HC; Kim HD; Lee JS
Pediatr Neurol; 2010 Feb; 42(2):86-92. PubMed ID: 20117743
[TBL] [Abstract][Full Text] [Related]
7. Prospective assessment of levetiracetam pharmacokinetics during dose escalation in 4- to 12-year-old children with partial-onset seizures on concomitant carbamazepine or valproate.
Fountain NB; Conry JA; Rodríguez-Leyva I; Gutierrez-Moctezuma J; Salas E; Coupez R; Stockis A; Lu ZS
Epilepsy Res; 2007 Apr; 74(1):60-9. PubMed ID: 17270398
[TBL] [Abstract][Full Text] [Related]
8. Once-daily extended-release levetiracetam as adjunctive treatment of partial-onset seizures in patients with epilepsy: a double-blind, randomized, placebo-controlled trial.
Peltola J; Coetzee C; Jiménez F; Litovchenko T; Ramaratnam S; Zaslavaskiy L; Lu ZS; Sykes DM;
Epilepsia; 2009 Mar; 50(3):406-14. PubMed ID: 19317886
[TBL] [Abstract][Full Text] [Related]
9. Levetiracetam in children, adolescents and young adults with intractable epilepsy: efficacy, tolerability and effect on electroencephalogram--a pilot study.
Goldberg-Stern H; Feldman L; Eidlitz-Markus T; Kramer U; Perez S; Pollak L; Phatal-Valevski A
Eur J Paediatr Neurol; 2013 May; 17(3):248-53. PubMed ID: 23159714
[TBL] [Abstract][Full Text] [Related]
10. Adjunctive levetiracetam in infants and young children with refractory partial-onset seizures.
Piña-Garza JE; Nordli DR; Rating D; Yang H; Schiemann-Delgado J; Duncan B;
Epilepsia; 2009 May; 50(5):1141-9. PubMed ID: 19243423
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of levetiracetam as an add-on therapy in children aged less than 4 years with refractory epilepsy.
Li S; Cao J; Xiao N; Cai F
J Child Neurol; 2010 May; 25(5):609-13. PubMed ID: 19779208
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of levetiracetam 1000-3000 mg/day in patients with refractory partial-onset seizures: a multicenter, open-label single-arm study.
Beran RG; Berkovic SF; Black AB; Danta G; Hiersemenzel R; Schapel GJ; Vajda FJ
Epilepsy Res; 2005 Jan; 63(1):1-9. PubMed ID: 15716083
[TBL] [Abstract][Full Text] [Related]
13. Levetiracetam monotherapy for childhood occipital epilepsy of gastaut.
Verrotti A; Parisi P; Loiacono G; Mohn A; Grosso S; Balestri P; Tozzi E; Iannetti P; Chiarelli F; Curatolo P
Acta Neurol Scand; 2009 Nov; 120(5):342-6. PubMed ID: 19754870
[TBL] [Abstract][Full Text] [Related]
14. Use of levetiracetam in treating epilepsy associated with other medical conditions.
Di Bonaventura C; Mari F; Fattouch J; Egeo G; Vaudano AE; Manfredi M; Prencipe M; Giallonardo AT
Acta Neurol Scand; 2006 Feb; 113(2):82-6. PubMed ID: 16411967
[TBL] [Abstract][Full Text] [Related]
15. Intravenous levetiracetam in children with epilepsy.
Goraya JS; Khurana DS; Valencia I; Melvin JJ; Cruz M; Legido A; Kothare SV
Pediatr Neurol; 2008 Mar; 38(3):177-80. PubMed ID: 18279751
[TBL] [Abstract][Full Text] [Related]
16. Intravenous levetiracetam in children with seizures: a prospective safety study.
Ng YT; Hastriter EV; Cardenas JF; Khoury EM; Chapman KE
J Child Neurol; 2010 May; 25(5):551-5. PubMed ID: 20413804
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and tolerability of levetiracetam in children younger than 4 years: a retrospective review.
Perry MS; Benatar M
Epilepsia; 2007 Jun; 48(6):1123-7. PubMed ID: 17430408
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of levetiracetam in children with epilepsy younger than 2 years of age.
Krief P; Li Kan ; Maytal J
J Child Neurol; 2008 May; 23(5):582-4. PubMed ID: 18448575
[TBL] [Abstract][Full Text] [Related]
19. Levetiracetam in adult patients with and without learning disability: focus on behavioral adverse effects.
Brodtkorb E; Klees TM; Nakken KO; Lossius R; Johannessen SI
Epilepsy Behav; 2004 Apr; 5(2):231-5. PubMed ID: 15123025
[TBL] [Abstract][Full Text] [Related]
20. Neurocognitive effects of adjunctive levetiracetam in children with partial-onset seizures: a randomized, double-blind, placebo-controlled, noninferiority trial.
Levisohn PM; Mintz M; Hunter SJ; Yang H; Jones J;
Epilepsia; 2009 Nov; 50(11):2377-89. PubMed ID: 19702752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]